01-Oct-2026 20:12:06
PPLPHARMAGeneral news
PIRAMAL PHARMA LIMITED : COMMERCIAL ARRANGEMENT WITH BAYER TO EXPIRE
• Commercial arrangement for sales and distribution support services with Bayer Pharmaceuticals Private Limited to expire on December 31, 2026 • Arrangement will not be renewed beyond its current term • Company working with Bayer for a smooth transition • Arrangement primarily involved commission-based income, representing less than 5% of consolidated revenue • Non-renewal not expected to materially impact profitability or financial position Impact: Neutral (Contract expiration, revenue impact minimal)
Piramal Pharma Ltd
Open attachment